Azenta Q1 revenue $140M (+18% YoY); completes $3B sale of semiconductor business to THL

Azenta, Inc.

2022-Q1 EPS reported $0.58 revenue$139,652,000

GAAP diluted EPS from continuing ops $0.04; total diluted EPS $0.58 (incl. $0.54 from discontinued ops).
Life Sciences Products revenue $50M (+10% YoY); Services revenue $90M (+24% YoY).
Closed sale of semiconductor automation business on Feb 1, 2022 for $3.0B cash; net proceeds ~$2.4B; used $50M to extinguish debt.
Q2 FY2022 guidance: revenue $137-147M; non-GAAP EPS $0.07-0.15; GAAP EPS ($0.04)-$0.04.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.